Schedule 13D ownership disclosure

LA JOLLA PHARMACEUTICAL CO

Security class unavailable · CUSIP: 503459604

Event date: 2022-07-10

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
9,607,934
Percent of class
38.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-22-008768
Form type
SC 13D/A
Filer
LA JOLLA PHARMACEUTICAL CO
CIK
CIK 920465
Filed
Jul 12, 2022
Reporting period
Jul 10, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub